Learn More
In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as 'safe' alternatives' to(More)
BACKGROUND Benzylpiperazine (BZP) is the psychoactive ingredient in a range of 'legal highs' sold worldwide. BZP was prohibited in New Zealand in 2008. AIM To investigate the impact of the prohibition of BZP legal highs on the prevalence of BZP, replacement legal highs and other drugs. METHODS A population survey of BZP and other drugs was conducted in(More)
AIM To track trends in drug use in the New Zealand population over the past 8 years. METHOD National household surveys of drug use were conducted in New Zealand in 1998, 2001, 2003,and 2006 using the same Computer Assisted Telephone Interview (CATI) methodology. The age ranges of the random digit dial (RDD) samples from each survey wave were truncated to(More)
BACKGROUND 'Party' pills containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) were sold legally in New Zealand until early 2008. Prospective studies of hospital emergency department admissions appeared to suggest that the harm from party pills was greater among South Island than North Island users. The party pill industry(More)
This paper aims to set out some of the policy and public health issues raised by the appearance of a wide range of emergent psychoactive substances of diverse origin, effect and risk profile (commonly referred to as 'legal highs'). It will start by considering what is meant by the term 'legal highs' and consider the historical context that has framed their(More)
BACKGROUND Legal highs containing benzylpiperazine (BZP) were widely sold in New Zealand until BZP was prohibited in 2008. We examined the impact the prohibition had on the availability and price of BZP over following years. METHODS Two national population surveys of BZP use were conducted in 2006 and 2009. Four annual targeted surveys of frequent drug(More)
AIMS To examine changes in the use of ecstasy, current conditions of supply, harms resulting from use, and the demographics of users. METHODS National Drug Surveys were conducted in 1998 and 2001. In each survey, a representative national sample of approximately 5500 people aged 15-45 years were asked about their drug use, including ecstasy use, using a(More)
AIM To examine the impact of the emergence of cannabis 'tinny' houses on the use and sale of cannabis and other illicit drugs in New Zealand. METHOD A national sample of 5800 people aged 13-45 years were interviewed about their drug use using a computer-assisted telephone interview (CATI) system as part of the 2001 National Drug Survey. A question on(More)
New data collected on the procurement and purchase of cannabis in the 2001 New Zealand National Drug Survey are used to estimate the dollar value of the illicit market for cannabis as well conduct other economic analyses of the illicit purchase of cannabis in New Zealand. Eighty-four per cent of last-year cannabis users received at least some of their(More)
An intrinsic drawback with the use of a computer-assisted telephone interview (CATI) survey methodology is that people who live in households without a connected landline telephone are excluded from the survey sample. This paper presents a pilot of the feasibility of a computer-assisted cell-phone interview (CACI) methodology designed to survey people(More)